📰 Boxed Warning News
Page 33 - Boxed Warning News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Boxed Warning. Real-time updates on events, politics, business and more.
March 23, 2023
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and...
March 23, 2023
- Annual Net Product Sales Across the Company Grew 25% to $107.7 million in 2022, Compared to Annual Net Product Sales in 2021 - - APONVIE™ Commercially Launched on March 6, 2023 - - ZYNRELEF® Net Product Sales for Fourth Quarter of 2022 ...
March 8, 2023
/PRNewswire/ -- In honor of International Womens Day, Allergan Aesthetics, an AbbVie company (NYSE: ABBV) today announced that BOTOX® Cosmetic is partnering...
March 6, 2023
/PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing...
March 2, 2023
/PRNewswire/ -- Neurelis, Inc. is proud to announce the Give Seizures the Sprayer marketing campaign for VALTOCO® (diazepam nasal spray) CIV has won a 2023...
March 1, 2023
Full year 2022 total revenues of $250.3 million, compared to $83.8 million in 2021 CAPLYTA fourth quarter 2022 net product sales grew to $87.4 million, a...
March 1, 2023
Elucirem and Vueway (gadopiclenol) are now available for use to detect and visualize lesions with abnormal vascularity in the CNS and the body.
March 1, 2023
The FDA has approved Kevzara (sarilumab) for adults with polymyalgia rheumatica who have had an inadequate response to corticosteroids.
February 28, 2023
Scilex Holding Company has announced the relaunch of Elyxyb (celecoxib oral solution) for the treatment of acute migraine with or without aura in adults.
February 24, 2023
February FDA approvals include treatments for geographic atrophy, proteinuria, tardive dyskinesia and chorea associated with Huntington disease, and anemia.